"The entire pharmaceutical value chain, including companies in the biomedical field, are heavily impacted by what happens in medical and pharmacy benefit coverage and reimbursement decisions. Too often, we ignore the people who have the most power to decide – the plan sponsors. They are the large employers or government agencies whose coverage plan or designs dictate what is actually permitted and paid for in terms of treatment. Listen to what some industry experts think needs to change in the current economic model, where a middleman controls decisions but doesn’t have the fiduciary duty or real decision making power. Learn what really happens when middlemen control the dollars and how to raise awareness with plan sponsors to change the conversation around how to decide what therapies to pay for and how to prepare for higher-priced biologics and genetic-based medicines that are not commonly prescribed. Preauthorization and step edit logic won’t be the same nor will 3rd parties.
Ability Level: All
Session ID: 21090